article information

Shiraz E-Medical Journal: Vol.11, issue 1; e93798
published online: January 01, 2010
article type: Research Article
received: May 15, 2019
accepted: November 03, 2009

Thyroid Disorder in Systemic Lupus Erythematosus Patients in Southeast Iran

authors:

avatar Z Zakeri 1 , avatar M Sandooghi 1 , *

Assistant Professor, Department of Internal Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

how to cite: Zakeri Z, Sandooghi M. Thyroid Disorder in Systemic Lupus Erythematosus Patients in Southeast Iran. Shiraz E-Med J. 2010;11(1):e93798. 

Abstract

Background: We conducted this study to clarify the prevalence of thyroid dysfunction in
patients with Systemic Lupus Erythematosus (SLE) and compared it to a matched healthy
controls group.
Material and methods: Eighty-three SLE and 166 matched healthy controls underwent clinical
examination and laboratory evaluation for serum T3, T4, TSH and Thyroid peroxides antibody
(TPO AB).
Results: 24.1% of SLE patients and 13.3% of control group had thyroid dysfunction (p value
= 0.04). Clinical thyroid dysfunction was seen neither in SLE patients nor in the control
group. Elevated TSH levels were the most common dysfunction (19.3%) of the SLE, compared
with control group (5.4%). Positive TPO antibody was detected in 16.9% of SLE and
16.3% of the control group. Mean level of TPO antibody was higher in SLE patients with
thyroid dysfunction (137.05) than SLE patients without the disorder (30.8) (p value=0.007).
Conclusion: We concluded thyroid dysfunction was more frequent in SLE patients than in
healthy controls. Moreover, SLE patients with anti TPO were more likely to have thyroid
dysfunction than the control group.

Fulltext

This part is available in the PDF file.

References

  • 1.

    The references are available in the PDF file.